Ironwood Pharmaceuticals (IRWD) Debt Ratio (2013 - 2026)

Ironwood Pharmaceuticals (IRWD) has 13 years of Debt Ratio data on file, last reported at 1.35 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio rose 14.38% year-over-year to 1.35; the trailing twelve-month figure through Mar 2026 stood at 1.35 (up 14.38% YoY), and the FY2025 full-year result was 1.47, up 34.27% from the prior year.
• Debt Ratio declined to 1.35 in Q1 2026, from 1.47 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 1.7 in Q2 2025 to a low of 0.11 in Q1 2022.
• A 5-year average of 1.12 and a median of 1.08 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio grew 2.64% in 2024 and soared 58.61% in 2025, its largest moves.
• Tracing IRWD's Debt Ratio over 5 years: stood at 0.11 in 2022, then jumped by 852.8% to 1.06 in 2023, then increased by 3.46% to 1.1 in 2024, then surged by 34.27% to 1.47 in 2025, then dropped by 8.64% to 1.35 in 2026.
• Business Quant data shows IRWD's Debt Ratio at 1.35 in Q1 2026, 1.47 in Q4 2025, and 1.48 in Q3 2025.